Inactive Instrument

Perrigo Company Stock Nasdaq

Equities

US7142901039

Pharmaceuticals

End-of-day quote Nasdaq
- USD - Intraday chart for Perrigo Company
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 4.62B Sales 2025 * 4.83B Capitalization 4.23B
Net income 2024 * -74M Net income 2025 * 106M EV / Sales 2024 * 1.61 x
Net Debt 2024 * 3.21B Net Debt 2025 * 3.01B EV / Sales 2025 * 1.5 x
P/E ratio 2024 *
-21.4 x
P/E ratio 2025 *
194 x
Employees -
Yield 2024 *
3.55%
Yield 2025 *
3.78%
Free-Float 99.12%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW